Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial
© Zhao et al.; licensee BioMed Central Ltd. 2013
Received: 15 February 2013
Accepted: 30 May 2013
Published: 9 July 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|15 Feb 2013||Submitted||Original manuscript|
|21 Feb 2013||Author responded||Author comments - Yong Zhao|
|Resubmission - Version 2|
|21 Feb 2013||Submitted||Manuscript version 2|
|4 Mar 2013||Reviewed||Reviewer Report - Sigurd Lenzen|
|5 Apr 2013||Reviewed||Reviewer Report - Anne Joerns|
|26 Apr 2013||Author responded||Author comments - Yong Zhao|
|Resubmission - Version 3|
|26 Apr 2013||Submitted||Manuscript version 3|
|16 May 2013||Reviewed||Reviewer Report - Anne Joerns|
|17 May 2013||Reviewed||Reviewer Report - Sigurd Lenzen|
|25 May 2013||Author responded||Author comments - Yong Zhao|
|Resubmission - Version 4|
|25 May 2013||Submitted||Manuscript version 4|
|30 May 2013||Editorially accepted|
|9 Jul 2013||Article published||10.1186/1741-7015-11-160|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.